Sciformix: LabCorp makes another acquisition to expand its drug development services

Laboratory Corporation of America Holdings (NYSE: LH) said Monday it has acquired Sciformix Corp. for an undisclosed amount. The acquisition will expand Burlington-based LabCorp's drug development services, with Sciformix becoming part of Covance when the deal closes. "This acquisition strengthens our position in the later phases of drug and device development, particularly for post-marketing pharmacovigilance and market access solutions," said LabCorp CEO David King in a statement. "The...